Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2026
Agenda for the July 2026 PBAC meeting (25 March 2026)
25 March 2026 - The agenda for the July 2026 PBAC meeting is now available. ...
Posted by Michael Wonder on 25 Mar 2026
New public listings for Canadians living with pulmonary arterial hypertension
24 March 2026 - Merck announced today that British Columbia, Non-Insured Health Benefits (NIHB), Nova Scotia, Quebec and Veterans Affairs Canada ...
Posted by Michael Wonder on 20 Mar 2026
NHS spending watchdog to review evidence on Alzheimer’s treatments
20 March 2026 - England’s drugs costs watchdog is to look again at whether new treatments for Alzheimer’s disease should ...
Posted by Michael Wonder on 20 Mar 2026
DUSC utilisation analysis public release documents (October 2025)
20 March 2026 - The utilisation analysis public release documents from the October 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 20 Mar 2026
Public summary documents (first time decisions not to recommend and deferrals) – November 2025 PBAC meeting
20 March 2026 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2025 PBAC ...
Posted by Michael Wonder on 18 Mar 2026
When generic versions of weight loss drugs arrive, public plans should cover them, experts say
17 March 2026 - When Bonnie Evoy entered her mid 60s, she unexpectedly and rapidly gained weight. She tried for ...
Posted by Michael Wonder on 18 Mar 2026
Patients to get new medicines up to six months sooner
17 March 2026 - Patients in England are set to receive some new medicines 3 to 6 months earlier under a ...
Posted by Michael Wonder on 17 Mar 2026
PBAC advice on equitable access to GLP-1 obesity treatments
17 March 2026 - On 6 March 2025, Minister Butler wrote to the PBAC to request the Committee’s advice on ...
Posted by Michael Wonder on 15 Mar 2026
The end of cancer: how cell therapy breakthroughs have us on the edge of a cure
15 March 2026 - How rapid immunotherapy advancements could relegate killer cancers to the status of a ‘chronic disease’. ...
Posted by Michael Wonder on 12 Mar 2026
500,000 eligible to benefit from new non-hormonal treatment for hot flushes caused by menopause
11 March 2026 - A new treatment option for menopausal hot flushes and night sweats can be used in the NHS ...
Posted by Michael Wonder on 11 Mar 2026
PHARMAC to fund life‑changing treatments for children with cystic fibrosis
11 March 2026 - PHARMAC will fund new treatment options for people living with cystic fibrosis from 1 April 2026. ...
Posted by Michael Wonder on 10 Mar 2026
Cutting-edge cancer treatment research heading offshore as local patients miss out
11 March 2026 - Newsreader Will McDonald is six years into his fight with aggressive prostate cancer. He wants all Australians ...
Posted by Michael Wonder on 07 Mar 2026
Trump’s drive to get Europe to pay more for drugs creates uncertainty for countries, patients
2 March 2026 - Pharma is also eager to see the region increase spending on medicines. ...
Posted by Michael Wonder on 06 Mar 2026
Public summary documents – November 2025 PBAC meeting
6 March 2026 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2025 PBAC ...
Posted by Michael Wonder on 06 Mar 2026
Agenda for the March 2026 PBAC meeting (4 March 2026)
6 March 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...